gemcitabine has been researched along with abt-510 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carr, RA; de Vos, FY; Eskens, FA; Gietema, JA; Groen, HJ; Hoekstra, R; Humerickhouse, RA; Knight, RA; Loos, WJ; Uges, DR; van der Gaast, A | 1 |
1 trial(s) available for gemcitabine and abt-510
Article | Year |
---|---|
A phase I study assessing the safety and pharmacokinetics of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with gemcitabine and cisplatin in patients with solid tumors.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Drug Interactions; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasms; Oligopeptides; Thrombospondin 1 | 2006 |